Moreover, silencing eEF2K sensitizes human glioma cells to TNF-related apoptosis-inducing ligand (TRAIL), temozolomide, and 2-deoxy-D-glucose (2-DG) [11-13]. Here, TNFSF10 is linked to glioma.